Pharmaceuticals

Which Factors Will Push The Quinolones Market To Achieve $63.17 Billion By 2029?

September 23, 2025 by Marketing Posting

Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

#What Are The Market Size Estimates For The Quinolones Market?#_x000D_

The size of the quinolones market has exhibited steady growth in the past few years. The market which was valued at $50.05 billion in 2024, is projected to escalate to $51.89 billion in 2025, reflecting a compound annual growth rate (CAGR) of 3.7%. This growth during the historical period can be ascribed to factors such as defied demand and use of antibiotics, regulatory acquiescences, research and development activities, competition in the market, and patent expirations._x000D_

_x000D_

The market size of quinolones is projected to experience robust growth in the coming years, reaching “$63.17 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 5.0%. Factors contributing to this growth during the forecast period include the prevalence of new diseases, alterations in regulation, modifications in global health policies, increased antibiotic resistance, and strategies for market expansion. Notable trends during this time are anticipated to be the development of new products and shifts in the regulatory framework._x000D_

_x000D_

#Get A Free Sample Of The Report:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=9429&type=smp_x000D_

_x000D_

#What Market Forces Are Contributing To The Growth Of The Quinolones Market?#_x000D_

The surge in infectious diseases rates is playing a significant role in the expansion of the quinolones market. These diseases are caused by various microbes, including parasites, fungi, bacteria, and viruses. Quinolones are widely utilized in the treatment of numerous infectious diseases like tuberculosis and urinary tract infections which are bacterial in nature. For example, data from the Global Tuberculosis Report by the World Health Organization, based in Switzerland, indicated a rise in newly diagnosed TB cases, escalating to 7.5 million in 2022 from 6.4 million in 2021. Thus, the increasing occurrence of infectious diseases consequently propels the growth of the quinolones market._x000D_

_x000D_

#What Is The Segment Breakdown Of The Quinolones Market?#_x000D_

The quinolones market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types_x000D_

2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen_x000D_

3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies_x000D_

_x000D_

Subsegments:_x000D_

1) By Norfloxacin: Indications, Dosage Forms _x000D_

2) By Ofloxacin: Indications, Dosage Forms _x000D_

3) By Ciprofloxacin: Indications, Dosage Forms _x000D_

4) By Gemifloxacin: Indications, Dosage Forms _x000D_

5) By Other Types: Various Formulations, Indications_x000D_

_x000D_

#How Are Global Trends Impacting The Development Of The Quinolones Market?#_x000D_

One of the prevailing trends in the quinolones market is product innovation, with major market players striving to create innovative products to maintain their dominance in the market. For instance, Viatris’s South Korean division, a pharmaceutical corporation headquartered in the United States, introduced Dovprela, a ground-breaking drug-resistant TB treatment, in January 2023. Dovprela, a combination of bedaquiline, pretomanid, and linezolid (BPaL), is designed for adults suffering from extensively drug-resistant TB or multidrug-resistant TB that does not respond to treatment. Due to its accelerated anti-tuberculosis action, Dovprela cuts the treatment time from 18-20 months to just 5-6 months._x000D_

_x000D_

#Which Firms Are Driving Innovation Within The Quinolones Market?#_x000D_

Major companies operating in the quinolones market include Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, Novus, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd. _x000D_

_x000D_

#Access The Complete Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report_x000D_

_x000D_

#Which Region Is Likely To Register The Fastest Growth In The Quinolones Market?#_x000D_

North America was the largest region in the quinolones market in 2024. The regions covered in the quinolones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Customize Your Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=9429&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_